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Antifertility and histopathological investigations were carried out on reproductive organs of male albino rats induced by tetraaza-
macrocyclic complexes of iron(II). The complexes were synthesized by the template condensation of 1,2-diaminoethane, 1,3-
diaminopropane with succinic acid and phthalic acid in 2 : 2 molar ratios which are abbreviated as [Fe(TAMLn)OAc] (n = 1o r
2a n dT A M L n represents tetraazamacrocyclic ligand). The complexes have been characterized by elemental analysis, conductivity
measurements, IR, and electronic spectra.
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INTRODUCTION
Today, rapidly expanding population and limited sources are
thought to be the most pressing global problems. This rapid
increase in the world population has multiplied the bene-
ﬁts of economical and technological advancements. Fertil-
ity control is very essential for maintaining satisfactory stan-
dards in the developing countries. There is an increasing
international recognition for the need to control human fe-
cundity. Needless to say there is an immediate need for an
inexpensive, safe, and eﬀective as well as universally accept-
able contraceptive. For evolution of such an ideal method for
control of human fertility, it is necessary that the reproduc-
tive process both of male and female need to be more inten-
sively investigated.
The population of India is multiplying at an alarming
rate and has almost crossed one billion by this time. Fertil-
ity regulation has therefore become the major concern for
the people of all the walks of life. The dramatic success of
oral contraceptives in women and the lack of pill for man
have stimulated research in male fertility control. The devel-
opment of new and improved contraception agent for men
has lagged behind the development of female contraceptives.
The male, an integral part of the family unit, has largely
beensidelinedbyfamilyplanners.Currently,eﬀortsarebeing
made to develop a male contraceptive agent, which would
inhibit fertility without aﬀecting sex accessory function and
libido. In this endeavor, a variety of synthetic compounds
have been evaluated in males of laboratory species of mam-
mals[1–5].Theresultsobtainedarealsoencouraging.There-
fore, this approach may form the basis for clinical regula-
tion of male fertility in future. Inorganic compounds have
also been investigated and applied for antifertility activity
only and have not been screened for toxicological eﬀect [6–
9]. In this context, the present communication deals with
the synthesis, characterization, and contraceptive eﬃcacy
of iron(II) tetraazamacrocyclic complexes. The complexes
screened were investigated for their antifertility eﬃcacy at
biochemical and histopathological levels.
The tetraazamacrocyclic complexes of iron(II) reported
in this paper have been synthesized for the ﬁrst time. The
complexes have been isolated in pure form through crystal-
lization. These show good antifertility activity and may be
useful for medicinal purpose. Further, it has been reported
that manganese salts (chloride, nitrate, and acetate) cause
loss of testicular germ cells in rats and rabbits, and decreased
l i b i d oa n di m p o t e n c yw e r en o t e di nm e no c c u p a t i o n a l l ye x -
posed to manganese [10]. Similarly, macrocyclic complexes
of manganese(II) and iron(II) exhibit a broad spectrum of
antimicrobial, antiinﬂammatory, analgesic, and antifertility2 Bioinorganic Chemistry and Applications
activity [11]. The above discussion has inspired us to syn-
thesize tetraazamacrocyclic complexes of iron(II) and then
screen them for their antifertility activity.
EXPERIMENTS
Synthesis
Materialsandmethods
The chemicals including succinic acid, phthalic acid (Fluka
chemie AG, Industriestrasse, CH 9471, Buchs, Switzerland),
1,2-diaminoethane, 1,3-diaminopropane (Merck Limited
India, Shiv Sagar Estate A, Dr, Annie Besant Road, Worli,
Mumbai 400018), and Fe(CH3COO)2 (BDH) were used.
Synthesisof2,5,10,13-tetraoxo-1,6,9,14-tetraazacyclohexa
decaneiron(II):[Fe(TAML1)(OAc)2]
T h er e a c t i o nw a sc a r r i e do u ti n1:2:2m o l a rr a t i o s .F e −
(CH3COO)2 (5mmol) was dissolved in methanol (25mL)
and cooled in an ice bath. To this solution, taken in a 100mL
round bottom ﬂask, was added 1,2-diaminoethane [corre-
sponding to Fe(CH3COO)2]i nm e t h a n o l( 2 5m L ) .T h er e -
sulting mixture was stirred for 25–30h. The solid product
was isolated by ﬁltration, repeatedly washed with the same
solvent, and dried in vacuo. The compound was recrystal-
lized in benzene and again dried in vacuo.
Synthesisof3,4,12,13-dibenzo-2,5,11,14-tetraoxo-1,6,10,
15-tetraazacyclooctadecaneiron(II):[Fe(TAML2)(OAc)2]
The same experimental procedure as for [Fe(TAML1)-
(OAc)2]wasused.Thereagentsusedforthispurposeare1,3-
diaminopropane and phthalic acid.
Analyticalmethodsandphysicalmeasurements
Nitrogen was estimated by Kjeldahl’s method. Iron was es-
timated gravimetrically. Carbon and hydrogen analyses were
performedatRegionalSophisticatedInstrumentationCentre
of Central Research Drugs Institute, Lucknow. Conductiv-
ity measurements were made with a Systronic (Model 305)
conductivity bridge in dry dimethylformamide. Molecular
weights were determined by the Rast Camphor method. The
IR spectra of the solid samples were recorded as KBr discs
on a Nicolet Magna FTIR-550 spectrophotometer. Electronic
spectrawererecorded,intherange200–600nm,usingmeth-
anol as the solvent on a UV-160A Shimadzu spectropho-
tometer.
Antifertilityactivity
In the present investigations, healthy adult male albino rats
(Rattus norvegicus) each having weight between 200–250g of
proven fertility were used. These were preferred over other
laboratory mammals because of their medium size, relatively
double nature, easy in handling and maintenance, size, rel-
atively tocile nature, covertly observable sex and libido, and
Table 1: Treatment and autopsy days for iron(II) complexes.
Group Experimental protocol
Number of Treatment Autopsy
animals used days day
Control 5 — 61st
[Fe(TAML1)(CH3COO)2] 5 60 61st
Withdrawal 5 60 to 30 91st
[Fe(TAML2)(CH3COO)2] 5 60 61st
Withdrawal 5 60+30 91st
in having a relatively short gestation period of 23–30 days.
Animals were regularly checked for any disease and if found
infectedwereisolatedand treated.Animals werefedonadiet
of ratfeedpelletsobtained fromHindustanLeverLtd, Mum-
bai, India, and soaked gram. Water was provided ad libitum.
In these investigations, doses of the compounds mixed
in vehicle (olive oil) were given orally with the help of hy-
podermic syringe having pearl point needle, for 60 days and
withdrawal (recovery) for 30 days (Table 1).
The LD50 is a statistically derived single dose of a sub-
stance that can be expected to cause death in 50% of the an-
imals. In a prohibited analysis method of LD50, the selected
dose levels should bracket the expected LD50 v a l u ew i t ha t
least one dose level higher than the expected LD50 but not
causing 100% mortality and one dose level below the ex-
pected LD50 but not causing 0% mortality. Toxicity of the
complexes was determined by calculating the LD50 values.
Symptoms of poisoning and mortality were observed and re-
sults of toxicity were analyzed for determination of LD50 val-
uesofthecomplexes.OnthebasisofLD50,valuesthepresent
(only single) dose of the compounds were decided forthe ex-
periment.
Fertilitytest
After the completion of the treatment, the fertility test was
done. On day 61, the animals were autopsied and blood was
extracted from heart. The serum was separated and used for
serumbiochemistry.Reproductivetissues(testis,epididymis,
vas deferens, seminal vesicle, and ventral prostate) and vital
organs (liver, kidney, heart, and adrenal) were blotted free of
blood, weighed, and used for tissue biochemistry and histol-
ogy.
Bodyandorganweights
Initial and ﬁnal body weights of animals were taken before
andafterthetreatment.Themeanvalueofeachofthetissues
was calculated.
Spermatozoamotilityandcount
The spermatozoa motility was determined according to the
method of Prasad et al [12] using WBC counting Neubauer
chamber of a hemocytometer and was expressed as million
spermatozoa/mL suspension.A. Chaudhary and R. V. Singh 3
Table 2: Physical properties and analytical data of iron(II) complexes.
Compound Color and
MP (◦C) Yield (%) Analysis % found (calcd.) Mol. wt. found
(calcd.) CHNF e
[Fe(TAML1)(CH3COO)2] Brown 63 41.81 5.62 11.28 11.74 439
115 (41.96) (5.72) (12.23) (12.19) (458)
[Fe(TAML2)(CH3COO)2] Brown 67 53.50 5.10 8.78 9.15 559
129 (53.66) (5.20) (9.63) (9.60) (582)
Biochemicalstudies
Protein was estimated by Lowry et al’s [13] method. Sialic
acid was estimated by the procedure given by Warren [14].
Cholesterol was done as per the method of Zlatkis et al [15].
Glycogen was estimated by the method of Montgomery [16].
Fructose was done by the method of Foreman et al [17].
Ascorbic acid was estimated by the method of Roe and Kue-
ther [18]. Acid phosphatase and alkaline phosphatase were
measured by the method of Fiske and Subbarow [19].
RESULTS AND DISCUSSION
Synthetic
The complexes are colored solids and soluble in most of the
organic solvents like methanol, benzene, dichloromethane,
tetrahydrofuran, and dimethylformamide. Their nonelectro-
lytic nature was conﬁrmed by low molar conductance values
15–23Ohm−1cm2 mol−1. Physical properties and analytical
data of the complexes are given in Table 2.
IRspectra
The IR spectra of the starting materials and their iron com-
plexes were recorded and their comparative study conﬁrmed
the formation of macrocyclic complexes with the proposed
coordination pattern. The bands observed in the region
3420–3531cm−1 attributed to −NH2 of amino and 2500–
2590cm−1 attributed to −OH of the carboxylic acid. Both
of these bands (−NH2 and −OH) disappeared in the com-
plexes, conﬁrming the cyclization. A single sharp band is
observed at 3132cm−1 for [Fe(TAML1)(CH3COO)2]a n da t
3251cm−1 for [Fe(TAML2)(CH3COO)2]d u et oν(N−H) of
the amide group. The appearance of four bands at 1649,
1565,1271,and638cm−1 for[Fe(TAML1)(CH3COO)2],and
1687, 1561, 1249, and 670cm−1 for [Fe(TAML2)(CH3CO-
O)2]areduetotheamideI,amideII,amideIII,andamideIV
vibrations, respectively. The bands at 430cm−1 for [Fe-
(TAML1)(CH3COO)2] and 442cm−1 for [Fe(TAML2)(CH3-
COO)2] in the spectra of the complexes may be assigned
to (Fe−N) stretching vibrations. The absorption bands ob-
served in the regions 2880–2910 and 1420–1440cm−1 in the
complexesmaybereasonablyassignedtotheC−Hstretching
and bending vibrational modes.
To distinguish between these structures (enolic and am-
ide), we have synthesized the free ligands and recorded their
IR spectra. Surprisingly, there were no bands for the azome-
thine group (>C=N) in the IR spectra of the complexes. This
clearly indicated that the amide structure is the real struc-
ture in this case and not the enolic structure. The νasym and
νasy OCO of the acetate group appear at 1480 and 1330cm−1
(Δν150cm−1) suggesting the bonding mode of acetate group
[20]. A sharp band observed at 482 and 487cm−1 ascribed
to the Fe−O stretching vibrations in the complexes [Fe-
(TAML1)(CH3COO)2] and [Fe(TAML2)(CH3COO)2], re-
spectively. Similar results have also been conﬁrmed and re-
ported by other authors [21].
Electronicspectra
Aweakintensitybandexhibitedat11904and11278cm−1 for
[Fe(TAML1)(CH3COO)2] and [Fe(TAML2)(CH3COO)2],
respectively, is assigned to the 5T2g → 5Eg, transitions con-
sistent with an octahedral geometry for iron(II) complexes.
These assignments are also in tune with the results of Lobana
et al [22] and Chaudhary et al [23] for high-spin octahedral
iron(II) system.
On the basis of the above spectral studies, the derivatives
have been assigned the following structures with hexacoor-
dinated iron atom (Figure 1).
Antifertilityactivity
Bodyandorganweights
The data revealed that the body weights of rats were not
much altered after the treatment of [Fe(TAML1)(CH3CO-
O)2]a n d[ F e ( T A M L 2)(CH3COO)2], however, in both the
treated groups, a general decrease in the reproductive organ
weights was observed in relation to the control. A signiﬁcant
reduction was observed in weights of testis (P<0.01), epi-
didymis (p<0.001), seminal vesicle (p<0.01) and ventral
prostate (p<0.001) in [Fe(TAML1)(CH3COO)2]t r e a t e d
animals. The treatment of [Fe(TAML2)(CH3COO)2] also re-
sulted in a signiﬁcant decrease in the weights of testis (p<
0.001), epididymis (P<0.001), vas deferens (p<0.01), sem-
inal vesicle (p<0.001), and ventral prostate (p<0.01).
After the withdrawal of both of the compounds, the re-
sults favour that [Fe(TAML1)(CH3COO)2] was compara-
tively better in treatment. The vital organs data (Table 3) also
show similar results as reported for reproductive organs in
Table 4.
Spermatozoamotilityandcount
The spermatozoa motility of [Fe(TAML1)(CH3COO)2]
and [Fe(TAML2)(CH3COO)2] treated rats showed that the4 Bioinorganic Chemistry and Applications
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Figure 1: Proposed structures of the complexes.
Table 3: Vital organ weight (mg/100g body wt.) in [Fe(TAML1)(CH3COO)2]a n d[ F e ( T A M L 2)(CH3COO)2] treated and withdrawal group
of rats. Values are mean ±SE.
Group Vital organ (mg)
Liver Heart Kidney Adrenal
Control 3038.60 ±180.20 254.70 ±8.39 288.08 ±4.35 9.40 ± 0.40
[Fe(TAML1)(CH3COO)2] 3220.54 ±110.42 272.09 ±6.54 330.20 ±17.25 12.02 ±0.60
Withdrawal (30 days) 3550.29 ±140.39 335.70 ±7.45 340.55 ±7.54 13.95 ±0.89
[Fe(TAML2)(CH3COO)2] 2579.50NS ±360.50 255.70 ±5.90 255.60 ±4.47 11.78 ±0.52
Withdrawal (30 days) 4452.86 ±130.23 346.60 ±18.95 348.10 ±20.02 7.99 ±0.73
NS = not signiﬁcant
Table 4: Body (g) and reproductive organ weights (mg/100g body wt.) in [Fe(TAML1)(CH3COO)2]a n d[ F e ( T A M L 2)(CH3COO)2] treated
and withdrawal group of rats. Values are mean ±SE.
Group
Body Wt. (g) Reproductive organ (mg)
Initial Final Testis Epididymis Vas deferens Seminal
vesicle
Ventral
prostate
Control 202.50 ±5.45 212.50 ±4.51 641.09 ±12.50 243.13 ±4.86 42.05 ±1.50 207.21 ±8.33 123.92 ±3.82
[Fe(TAML1)(CH3COO)2] 163.60 ±18.00 194.00 ±16.05 541.16b ±25.80 201.37b ±5.70 40.90 ±0.82 147.67b ±13.67 95.40a ±1.32
Withdrawal (30 days) 210.72 ±18.62 240.27 ±18.62 505.16 ±20.02 184.83 ±7.12 50.40 ±2.76 138.60 ±5.48 180.79 ±6.96
[Fe(TAML2)(CH3COO)2] 285.20 ±3.30 255.20 ±1.87 540.35a ±16.10 160.84a ±9.19 35.25b ±0.345 128.07a ±7.89 96.39b ±5.25
Withdrawal (30 days) 266.00 ±9.85 285.40 ±4.69 404.65 ±10.08 142.98 ±0.69 47.98 ±0.69 106.44 ±6.99 105.96 ±2.89
a = p<0.001, b = p<0.01.
sperms were sluggishly motile without any forward progres-
sion. The motility percent after [Fe(TAML1)(CH3COO)2]
treatmentdeclinedsigniﬁcantly(p<0.001).Followingwith-
drawal of the treatment, the sperms were actively motile
showing forward progression and the sperm motility per-
centage of the above groups recovered completely to normal
level (Table 5). The sperm density of cauda epididymis and
testicular sperm density diminished signiﬁcantly (p<0.001)
in [Fe(TAML1)(CH3COO)2] and [Fe(TAML2)(CH3COO)2]
treated rats and restored partially following 30 days with-
drawal in both the groups (Table 5).
Fertilitytest
Normal proestrous females after mating with the males of
proven fertility deliver on average 8–10 pups per female. The
treated animals exhibited normal libido and mating behav-
iour, however, in [Fe(TAML1)(CH3COO)2] treated animals,
the fertility test gave 90% negative fertility rate and in [Fe-
(TAML2)(CH3COO)2] treated group, the fertility test was
72% negative. Following withdrawal of the drug, 25% recov-
ery in fertility rate was observed in [Fe(TAML1)(CH3CO-
O)2] treated group of the animals, whereas 42% recoveryA. Chaudhary and R. V. Singh 5
Table 5: Sperm motility, sperm density and fertility rate of control, [Fe(TAML1)(CH3COO)2]a n d[ F e ( T A M L 2)(CH3COO)2] treated and
withdrawal group of rats. Values are mean ±SE.
Group Sperm motility (%) Sperm density (million/mL) Fertility (%)
Cauda epididymis Testis
Control 60.79 ±1.29 53.54 ±0.38 5.29 ±0.87 100% +ve
[Fe(TAML1)(CH3COO)2]2 5 .55 ±1.59a 13.54 ±2.50a 1.30 ±0.12a 90% −ve
Withdrawal (30 days) 62.95 ±4.57 20.55 ±4.93 2.25 ±0.35 25% +ve
[Fe(TAML2)(CH3COO)2]3 6 .90 ±2.45a 19.99 ±2.98a 1.28 ±0.28a 72.0% −ve
Withdrawal (30 days) 67.98 ±1.24 20.50 ±3.54 1.35 ±3.54 42.0% +ve
a = p<0.001, b = p<0.01.
Table 6:Protein,sialicacid,fructoseandcholesterolconcentrationofcontrol,and[Fe(TAML1)(CH3COO)2]and[F e(T AML 2)(CH3COO)2]
treated and withdrawal group of rats. Values are mean ±SE.
Group
Control [Fe(TAML1)(CH3COO)2] Withdrawal [Fe(TAML2)(CH3COO)2] Withdrawal
(30 days) (30 days)
Protein (mg/g)
Testis 85.04 ±4.30 75.09 ±5.89 107.70 ±8.88 32.57a ±4.57 80.45 ±1.40
Cauda epididymis 56.40 ±2.70 50.24 ±4.23 65.10 ±7.23 42.88b ±1.29 50.99 ±4.20
Ventral prostate 130.09 ±3.10 124.48 ±9.64 120.99 ±15.18 83.09a ±2.50 144.09 ±1.26
Sialic acid (mg/g) Testis 1.18 ±0.05 0.65a0.03 0.72 ±0.03 0.83a ±0.015 0.79 ±0.03
Cauda epididymis 0.95 ±0.007 0.56a ±0.007 0.71 ±0.02 0.82a ±0.029 0.83 ±0.006
Cholesterol (mg/g) Adrenal 14.50 ±0.30 22.49a ±1.58 18.25 ±0.07 27.19a ±1.75 10.88 ±0.40
Testis 6.13 ±0.30 15.99a ±1.20 7.82 ±0.09 7.54 ±0.90 7.20 ±0.10
Fructose (mg/g) Seminal vesicle 0.25 ±0.014 0.13a ±0.004 0.22 ±0.012 0.17a ±0.003 0.28 ±0.028
a = p<0.001, b = p<0.01.
in fertility rate was observed in the animals treated with
[Fe(TAML2)(CH3COO)2]( Table 5).
Biochemicalchanges
Proteins
The protein concentration of the reproductive organs was
lowered after the treatment of [Fe(TAML1)(CH3COO)2]a s
compared to the control which was brought to the normal
level in testis and cauda epididymis after the withdrawal of
thedrug(Table 6).Asigniﬁcantreductionintheproteincon-
tents of testis (p<0.001), cauda epididymis (p<0.01),
and ventral prostate (p<0.001) was observed following the
treatment of [Fe(TAML1)(CH3COO)2]. The above changed
parameters were restored completely to normal in all the or-
gans after the withdrawal of the drug (Table 6).
Sialicacid
Thetesticularandcaudaepididymalsialicacidconcentration
of [Fe(TAML1)(CH3COO)2]a n d[ F e ( T A M L 2)(CH3COO)2]
treated animals decreased signiﬁcantly (p<0.001). With-
drawal period of 30 days did not bring much change in the
above content (Table 6).
Fructose
Thefructoseconcentrationofseminalvesiclewasdiminished
signiﬁcantly (p<0.001) in [Fe(TAML1)(CH3COO)2]a n d
[Fe(TAML2)(CH3COO)2] treated animals, which was recov-
ered to the normal level after the withdrawal of the drug
(Table 6).
Cholesterol
The cholesterol and testicular cholesterol content of adre-
nal increased signiﬁcantly in [Fe(TAML1)(CH3COO)2]a n d
[Fe(TAML2)(CH3COO)2] treated animals in comparison to
thecontrol.Withdrawalofthetreatmentattainedthenormal
cholesterol and testicular cholesterol level (Table 6).
Glycogen
The glycogen concentration of testis was reduced in [Fe-
(TAML1)(CH3COO)2] treated animals as compared to the
control, whereas an increase was observed in the testicular
glycogen level in [Fe(TAML2)(CH3COO)2]t r e a t e dg r o u p .
The above altered parameter was restored completely after
the withdrawal of the treatments (Table 7).
[Fe(TAML1)(CH3COO)2] treated group also resulted in
a signiﬁcant reduction in the liver glycogen concentration6 Bioinorganic Chemistry and Applications
Table 7: Concentration of glycogen, ascorbic acid, acid phosphate and alkaline phosphate of control [Fe(TAML1)(CH3COO)2], and
[Fe(TAML2)(CH3COO)2] treated and withdrawal group of rats. Values are mean ±SE.
Acid phosphatase Alkaline
Group Glycogen (mg/g) Ascorbic acid (mg/g) (mg/g/h) phosphatase
Testis Liver Testis Cauda epididymis Ventral prostate Ventral prostate
Control 3.50 ±0.27 22.92 ±0.85 0.17 ±0.002 0.15 ±0.004 5.45 ± 0.42 2.21 ±0.19
[Fe(TAML1)(CH3COO)2] 3.35 ±0.19 10.17 ±0.77a 0.13 ±0.004 0.12b ±0.002 2.19b ±0.017 1.39c ±0.16
Withdrawal (30 days) 3.69 ±0.29 20.88 ±0.22 0.12b ± 0.002 0.15 ±0.006 6.23 ± 0.26 2.50 ±0.29
[Fe(TAML2)(CH3COO)2] 4.38 ±0.34 23.19 ±0.32 0.11b ± 0.003 0.12b ±0.004 2.25 ± 0.23 1.57c ±0.19
Withdrawal (30 days) 3.18 ±0.46 11.97 ±0.77 0.17 ±0.006 0.19 ±0.002 3.87 ± 0.49 1.23 ±0.25
a = p<0.001, b = p<0.01 and c = p<0.05.
(p<0.001), which was brought to normal after the with-
drawal of the treatment. On the contrary, an increase in the
concentration of liver glycogen was evident following the
withdrawal (Table 7).
Ascorbicacid
Treatment with both the groups resulted in reduction in the
ascorbic acid concentration of testis. This decrease was more
signiﬁcant (p<0.001) in [Fe(TAML1)(CH3COO)2]t r e a t e d
group of rats. A decline in the ascorbic acid concentration
was also noticed in cauda epididymis in both the treated
groups.
The decrease was more signiﬁcant (p<0.01) in [Fe-
(TAML1)(CH3COO)2]. The above altered parameter was
brought to normal following 30 days withdrawal of the drug.
(Table 7).
Acidandalkalinephosphatase
A signiﬁcant decrease in the acid phosphatase content (p<
0.01) of ventral prostate was observed in the [Fe(TAML1)-
(CH3COO)2]a n d[ F e ( T A M L 2)(CH3COO)2]t r e a t e dg r o u p s ,
which was completely restored to normal after the with-
drawal in [Fe(TAML1)(CH3COO)2]. However, a partial re-
covery was observed in [Fe(TAML1)(CH3COO)2]t r e a t e d
group of animals (Table 7). Similar reduction was also evi-
denced in the concentration of alkaline phosphatase content
(p<0.05) of ventral prostate of both the groups.
Haematologyandserumbiochemistry
Haemoglobin and haematocrit values remained unaltered,
indicating normal blood physiology of all the groups of ani-
mals.However,treatmentwith[Fe(TAML1)(CH3COO)2]re-
sulted in increased serum cholesterol concentration (p<
0.01). The concentrations of VLDL, triglycerides, albumin
and A/G ratio were decreased. Treatment with [Fe(TAML1)-
(CH3COO)2] also caused a signiﬁcant increase in the serum
cholesterol concentration (p<0.01) while concentration of
VLDL (p<0.05), triglycerides (p<0.05), albumin, and
A/G ratio decreased. The protein and glubulin concentration
of serum was increased to some extent in both the treated
groups of the animals.
The changes which have been found in the investigating
parameters are found to be restoring to the normal partially
or completely ultimately recovered. The results (Table 8) in-
dicated that haemoglobin, haematocrit, protein, and albu-
min were restored completely following withdrawal of the
test compounds. However, VLDL, serum, A/G ratio, and
glubulin were restored partially after 30 days of the stoppage
of the compounds administration.
Serumtestosterone
TheELISAtest(Table 9)revealedasigniﬁcantreduction(p<
0.05) in circulating serum testosterone in both the treated
groups. Withdrawal of the drug for 30 days restored the
level of serum testosterone completely in [Fe(TAML1)(CH3-
COO)2] withdrawal group of rats while partial recovery was
observed in [Fe(TAML2)(CH3COO)2] withdrawal group of
animals.
Histocytometry
The histocytometric data of [Fe(TAML1)(CH3COO)2]t r e a t -
ed rats revealed a decrease in the seminiferous tubule diam-
eters, germinal epithelial cell height (p<0.001), and Leydig
cell diameter (p<0.001) of testis along with a signiﬁcant
decrease in the epithelial cell height (p<0.001) and muscle
layer thickness (p<0.001) of cauda epididymis. The epithe-
lial cell height of seminal vesicle also decreased as compared
to the control. A signiﬁcant decrease was noticed in the ep-
ithelial cell height (p<0.05) of ventral prostate and in the
muscle layer thickness and epithelial cell height (p<0.05)
of vas deferens. The above altered parameters were restored
following the withdrawal of the treatment (Table 10).
In [Fe(TAML1)(CH3COO)2] treated rats, a signiﬁcant
decrease was noticed in testicular seminiferous tubule diam-
eter (p<0.001), germinal epithelial cell height (p<0.001),
and Leydig cell diameter (p<0.01). The epithelial cell height
of cauda epididymis decreased signiﬁcantly (p<0.001) with
a decrease in muscle layer thickness. A signiﬁcant decrease in
the epithelial cell height of seminal vesicle (p<0.001) and
ventral prostate (p<0.001) was observed. The muscle layer
thickness and epithelial cell height of vas deferens were also
decreased.Withdrawalofthedrugregainedthenormallevels
(Table 11).A. Chaudhary and R. V. Singh 7
Table 8:Haematologyandserumbiochemistryofcontrol,[Fe(TAML1)(CH3COO)2]and[F e(T AML 2)(CH3COO)2]treatedandwithdrawal
groups of rats. Values are mean ± SE, VLDL represents very low density lipoproteins, Tg denotes triglycerides, A/G ratio denotes albu-
min/globulin ratio.
Group
Control [Fe(TAML1)(CH3COO)2] Withdrawal [Fe(TAML2)(CH3COO)2] Withdrawal
(30 days) (30 days)
Blood Haemoglobin (%) 13.97 ±0.04 13.23 ±0.16 13.74 ±0.04 13.54 ±0.14 13.37 ±0.30
Haematocrit (%) 47.08 ±0.39 44.89 ±0.40 45.76 ±0.39 46.29 ±0.20 46.03 ±0.40
Serum
Protein (G/dL) 6.97 ±0.09 7.98 ±0.13 9.99 ±1.43 9.52 ±0.39 8.09 ±0.13
Cholesterol (mg/dL) 52.04 ±0.87 64.23 ±0.45 59.67 ±0.56 64.99 ±0.45 61.88 ±0.54
VLDL (mg/dL) 23.54 ±1.09 22.23 ±1.07 19.55 ±0.88 26.98 ±0.75 14.98 ±0.76
Tg (mg/dL) 114.24 ±3.97 110.55 ±1.34 95.45 ±0.91 137.35 ±0.78 76.55 ±0.77
Albumin (G/dL) 3.29 ±0.03 3.45 ±0.02 3.81 ±0.02 3.66 ±0.01 3.10 ±0.02
A/G ratio 0.99 ±0.04 0.68 ±0.03 0.51 ±0.02 0.59 ±0.02 0.64 ±0.02
Globulim 3.47 ±0.23 4.89 ±0.02 6.50 ±1.11 5.71 ±0.19 4.88 ±0.12
b = p<0.01
c = p<0.05.
Table 9: Eﬀect of the test substances on serum testosterone con-
tent of control, [Fe(TAML1)(CH3COO)2]a n d[ F e ( T A M L 2)(CH3-
COO)2] treated, and withdrawal group of rats. Values are mean ±
SE.
Group Serum testosterone (mg/mL)
Control 1.3973 ±0.076
Fe(TAML1)(CH3COO)2 0.5975 ±0.002a
(50mg/day/rat for 60 days)
Withdrawal (30 days) 0.83 ±0.03
Fe(TAML2)(CH3COO)2 0.675 ±0.002a
(50mg/day/rat for 60 days)
Withdrawal (30 days) 1.81 ± 0.039
a = p<0.001.
Discussion
In the present study, the results indicated that the weights of
the body and vital organs were not aﬀected after the treat-
ment suggesting that the complexes have no side eﬀect or
toxicological eﬀect and maintained normal physiology of the
animals throughout the experiment.
(i) NJ Chinoy and MR Chinoy [24] reported that the
structuralandfunctionalintegrityofthereproductiveorgans
depends on the circulating level of the androgen, and any
small change in the androgen level results in the reduction in
theweightsofthereproductiveorgans.Inthepresentstudies,
decline in the circulating levels of testosterone was observed
in [Fe(TAML1)(CH3COO)2] and [Fe(TAML2)(CH3COO)2]
treatedanimalsleadingtoadecreaseintheorganweightsand
androgen-dependent parameters.
(ii) The reduction in the weight of the testis after the
treatmentinthepresentstudyrelatedtothelossofspermato-
zoa and spermatids, which make up a substantial proportion
of testicular volume, by the same token, as a consequence of
disruption of spermatogenesis [25–27].
(iii) The suppressed epididymal activity as evidenced by
the loss of the weight and histological alterations might be
due to antigonadotropic activity of the so-termed antian-
drogenic/estrogenic substances which lower the ABP pro-
duction by the sertoli cell and androgen synthesis by the
Leydig cells, thereby resulting in reduced levels of andro-
gen available to the epididymis for functional maintenance.
The requirement of relatively higher androgen threshold in
the epididymis has already been established by Gupta et al
[28].
(iv) Reduction in the weights of seminal vesicles, ventral
prostate, and vas deferens, also reﬂects an interference with
a n d r o g e no u tp u t .B h i w gad eeta l[ 29] have already correlated
the reductionin the weights ofsexaccessories,particularly of
the prostate, following treatment of cyproterone acetate. An-
tiandrogens are known to depress the uptake of testosterone
in the prostate and reduce binding of androgen to the hor-
monal receptors by a process of competitive inhibition as re-
ported by Sharma and Jacob [30].
(v) The sperm density and sperm motility have a di-
rect relationship to the fertility [31]. In the present study,
spermmotility anddensityoftestis andcaudaepididymis af-
ter[Fe(TAML1)(CH3COO)2]and[Fe(TAML2)(CH3COO)2]
treatments were signiﬁcantly declined. Rao [32]h a sr e -
ported declined sperm motility, resulting into decreased fer-
tility.
Immotile or sluggishly motile spermatozoa cannot pen-
etrate the cervical mucus, thus fail to fertilize the ova [33].
During the present course of the study, 90% negative fertility
rate was observed after [Fe(TAML1)(CH3COO)2]t r e a t m e n t ,
while it was 72% negative in the [Fe(TAML2)(CH3COO)2]
treated animals. It appears worthwhile to conclude that re-
duction in the sperm counts and motility recorded in treated
animals substantiates the antifertility activity. Further, alter-
ation in the various androgen-dependent biochemical pa-
rameters that in turn altered the internal milieu of the
epididymis [34] may also be responsible for the negative fer-
tility test. Withdrawal for 30 days in the groups treated with8 Bioinorganic Chemistry and Applications
Table 10: Histocytometric data of control, [Fe(TAML1)(CH3COO)2] treated and withdrawal group of rats. Values are mean ±SE.
Tissues Parameters (μm) Control Treated Withdrawal
Testis
Seminiferous tubule diameter (STD) 240.25 ±5.02 224.04 ±5.98 255.00 ±4.23
Germinal epithelial cell height (GECH) 92.10 ±2.70 54.23 ±2.34a 56.02 ±4.98
Ledyig cell diameter (LCD) 53.45 ±2.98 30.00 ±2.09a 42.03 ±3.98
Cauda epididymis Epithelial cell height (ECH) 47.50 ±3.29 21.92 ±2.57a 38.77 ±4.98
Seminal vesicle (ECH) 55.02 ±3.25 50.55 ±6.24 85.00 ±10.15
Ventral prostate (ECH) 37.55 ±4.78 21.54 ±3.28c 31.05 ±4.13
Vas deferens (MLT) 355.24 ±12.27 328 ±7.54 475.05 ±13.28
(ECH) 50.02 ±2.40 40.77 ±3.77c 94.05 ±4.93
a = p<0.001
b = p<0.01.
Table 11: Histocytometric data of control, [Fe(TAML2)Cl2] treatment and withdrawal group of rats. Values are mean ± SE
Tissues Parameter (μm) Control Treated Withdrawal
Testis
STD 240.45 ±4.93 105.2 ±5.9a 140.05 ±5.83
GECH 88.55 ±2.79 38.27 ±2.4a 63.10 ± 5.83
LCH 48.23 ±3.24 30.55 ±3.0b 45.70 ± 6.73
Cauda epididymis ECH 47.25 ±3.77 15.43 ±2.00a 33.90 ± 3.19
MLT 66.23 ±4.93 58.55 ±3.70 63.70 ± 5.92
Seminal vesicle ECH 56.05 ±4.67 10.32 ±1.44a 47.45 ± 2.64
Ventral prostate ECH 39.67 ±4.60 12.55 ±1.37a 45.40 ±+2.79
Vas deferens MLT 355.05 ±30.2 309.55 ±10.3 374.95 ±1.67
ECH 51.98 ±2.79 32.58 ±4.74 1 .00 ± 2.73
a = p<0.001
b = p<0.01.
[Fe(TAML1)(CH3COO)2]a n d[ F e ( T A M L 2)(CH3COO)2]
showed signiﬁcant recovery in the fertility rate, indicating
that the eﬀects brought about the synthetic compounds were
reversible.
(vi) Protein is involved in the alteration of almost every
physiological system and the total protein run parallel to the
growth and is sensitive to estrogen and androgen, respec-
tively, reported by Davis et al [35]. Jones [36]h a sr e p o r t e d
that protein level is directly correlated with the secretory ac-
tivity of the epididymis, which in turn depends on the an-
drogen levels.
In the present investigations, the reduction in the protein
concentration by the treatment may be attributed to the re-
duction in secretory activity because of the androgen depri-
vation eﬀe c t .K a m a le ta l[ 4] and Mali et al [37] also reported
similar results for the male albino rats.
(vii) Nag et al [38] have reported that an optimal level
of sialic acid in reproductive organs is essential for func-
tional integrity of spermatozoa. Our observations are in con-
sonance with those of Gupta and Ahmed [39] who have
reported a decrease in sialic acid concentration of testis,
cauda epididymis, seminal vesicle, and ventral prostate to al-
bino rats. Bhargava [40] reported decrease in the testicular
sialic acid concentration due to the antispermatogenic activ-
ity.
(viii) Mammalian cellsrequirecholesterol whichplays an
important role in acting as precursor molecule in the syn-
thesis of steriod hormone [41]. The requirement of choles-
terol for normal activity of testicular glands has been well
established by Biswas, Deb, and Johnson [42, 43]. Androgens
aresynthesizedfromcholesterol,butincreasedconcentration
may result in the reduction of fertility [44].
After the treatment with the eﬀective doses of both
the compounds, there was a signiﬁcant increase in the tes-
ticular and adrenal cholesterol concentration which is in
consonance with the results of Kamal et al [4], suggesting
thattheincreasedtesticularcholesterolconcentrationmaybe
correlated with its nonutilization by the system leading to a
fall in circulatory androgen in rats due to the antiandrogenic
activity.
(ix) Baijal et al [45] proposed that glycogen might rep-
resent a source of nourishment for the spermatozoa during
its development and maturation. The glycogen level declined
in testis and liver of the rats treatment with [Fe(TAML1)-
(CH3COO)2] .K a m a le ta l[ 4] have reported decreased con-
centration of glycogen in the rats due to its androgen depen-
dence, leading to various disorders in testis.
In contrast, treatment with [Fe(TAML2)(CH3COO)2]
caused a nonsigniﬁcant increase in the concentration of
glycogen of both the liver and testis. The same case has beenA. Chaudhary and R. V. Singh 9
reported by Ewing et al [46]. Increased carbohydrate utiliza-
tion has been considered due to androgenic stimulation sug-
gesting a direct correlation between testosterone secretion
rate and glucose uptake by the isolated and perfused rabbit
testis as reported by Ewing et al [46].
(x) After treatment with eﬀective doses of [Fe(TAML1)-
(CH3COO)2]and[F e(T AML 2)(CH3COO)2],therewasade-
crease in the testicular and cauda epididymal ascorbic acid
concentration, which is in consonance with that of Chater-
jee et al [47] who reported hypofunctioning of testis and the
degeneration of the germinal epithelium due to vitamin C
deﬁciency.
(xi) Decline in acid phosphate level might be due to an-
tiandrogenic eﬀect or might be due to suppressed secretory
function of the prostate [28, 32, 44]. The acid phosphate val-
ues during present course of the study concur with the ﬁnd-
ings of Jacob et al [48].
Administration of the test substances resulted in a sig-
niﬁcant reduction in the alkaline phosphate content of the
ventral prostate. It is evident that this decrease was a likely
consequence of spermatogenic arrest as a result of suppres-
sionofandrogenesis.Thisobservationconcurswiththeﬁnd-
ings of others also [4, 44, 48], who reported a general decline
in the alkaline phosphate content of the various reproduc-
tive and accessory organs of the male rats after androgen-
estrogen therapy.
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